Ralf Kuriyel's most recent trade in Repligen Corp. was a trade of 4,826 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,826 | 16,448 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,542 | 4,542 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 155.38 per share. | 03 Mar 2025 | 386 | 16,062 (0%) | 0% | 155.4 | 59,977 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.54 per share. | 27 Feb 2025 | 391 | 11,622 (0%) | 0% | 156.5 | 61,207 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.74 per share. | 24 Feb 2025 | 275 | 12,013 (0%) | 0% | 164.7 | 45,304 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 159.36 per share. | 02 Aug 2024 | 6,973 | 12,288 (0%) | 0% | 159.4 | 1,111,217 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.10 per share. | 02 Aug 2024 | 175 | 12,463 (0%) | 0% | 86.1 | 15,068 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 175 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 158.85 per share. | 02 Aug 2024 | 175 | 12,288 (0%) | 0% | 158.9 | 27,799 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 165.67 per share. | 01 Aug 2024 | 4,465 | 19,261 (0%) | 0% | 165.7 | 739,717 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 163.34 per share. | 14 May 2024 | 534 | 23,726 (0%) | 0% | 163.3 | 87,224 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 193.73 per share. | 11 Mar 2024 | 3,517 | 24,260 (0%) | 0% | 193.7 | 681,348 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 1,271 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.10 per share. | 11 Mar 2024 | 1,271 | 27,777 (0%) | 0% | 86.1 | 109,433 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.72 per share. | 07 Mar 2024 | 386 | 26,506 (0%) | 0% | 195.7 | 75,548 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 193.99 per share. | 04 Mar 2024 | 135 | 26,892 (0%) | 0% | 194.0 | 26,189 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.79 per share. | 29 Feb 2024 | 453 | 27,027 (0%) | 0% | 191.8 | 86,881 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 404 | 27,480 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Kuriyel Ralf | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 3,520 | 27,076 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 3,497 | 3,497 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.03 per share. | 16 May 2023 | 710 | 23,556 (0%) | 0% | 154.0 | 109,361 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,591 | 25,513 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,591 | 3,591 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,468 | 21,922 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.00 per share. | 02 Mar 2023 | 1,247 | 24,266 (0%) | 0% | 188 | 234,436 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.44 per share. | 28 Feb 2023 | 458 | 18,812 (0%) | 0% | 173.4 | 79,436 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.28 per share. | 28 Feb 2023 | 358 | 18,454 (0%) | 0% | 173.3 | 62,034 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 254.14 per share. | 11 Aug 2022 | 4,040 | 19,270 (0%) | 0% | 254.1 | 1,026,726 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 2,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.05 per share. | 11 Aug 2022 | 2,000 | 22,110 (0%) | 0% | 33.1 | 66,100 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 1,354 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.52 per share. | 11 Aug 2022 | 1,354 | 23,464 (0%) | 0% | 59.5 | 80,590 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 255.20 per share. | 11 Aug 2022 | 800 | 23,310 (0%) | 0% | 255.2 | 204,160 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 646 | 400 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.10 per share. | 11 Aug 2022 | 646 | 24,110 (0%) | 0% | 86.1 | 55,621 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.40 per share. | 13 May 2022 | 712 | 20,110 (0%) | 0% | 150.4 | 107,085 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2022 | 4,234 | 22,406 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 196.70 per share. | 27 Feb 2022 | 1,584 | 20,822 (0%) | 0% | 196.7 | 311,573 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 196.70 per share. | 27 Feb 2022 | 477 | 18,645 (0%) | 0% | 196.7 | 93,826 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 196.70 per share. | 27 Feb 2022 | 473 | 18,172 (0%) | 0% | 196.7 | 93,039 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,723 | 2,723 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,126 | 19,310 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.21 per share. | 24 Feb 2022 | 188 | 19,122 (0%) | 0% | 189.2 | 35,571 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 450 | 17,359 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.42 per share. | 17 Feb 2022 | 175 | 17,184 (0%) | 0% | 182.4 | 31,924 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.53 per share. | 14 Dec 2021 | 445 | 16,909 (0%) | 0% | 252.5 | 112,376 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 282.13 per share. | 30 Aug 2021 | 4,001 | 17,354 (0%) | 0% | 282.1 | 1,128,802 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 189.19 per share. | 10 Jun 2021 | 6,802 | 21,355 (0%) | 0% | 189.2 | 1,286,870 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.52 per share. | 10 Jun 2021 | 2,557 | 27,112 (0%) | 0% | 59.5 | 152,193 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 2,557 | 1,354 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 1,045 | 2,092 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.10 per share. | 10 Jun 2021 | 1,045 | 28,157 (0%) | 0% | 86.1 | 89,975 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 172.29 per share. | 14 May 2021 | 710 | 24,555 (0%) | 0% | 172.3 | 122,326 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 190.08 per share. | 10 Mar 2021 | 6,354 | 26,911 (0%) | 0% | 190.1 | 1,207,768 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.87 per share. | 10 Mar 2021 | 5,850 | 33,115 (0%) | 0% | 33.9 | 198,140 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 5,850 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.05 per share. | 10 Mar 2021 | 2,000 | 27,265 (0%) | 0% | 33.1 | 66,100 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 192.13 per share. | 10 Mar 2021 | 1,004 | 25,265 (0%) | 0% | 192.1 | 192,899 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 191.33 per share. | 10 Mar 2021 | 642 | 26,269 (0%) | 0% | 191.3 | 122,834 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.52 per share. | 10 Mar 2021 | 150 | 33,265 (0%) | 0% | 59.5 | 8,928 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 150 | 3,911 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 190.06 per share. | 04 Mar 2021 | 700 | 25,265 (0%) | 0% | 190.1 | 133,042 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 191.20 per share. | 04 Mar 2021 | 600 | 25,965 (0%) | 0% | 191.2 | 114,720 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 196.23 per share. | 04 Mar 2021 | 400 | 26,940 (0%) | 0% | 196.2 | 78,492 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 192.24 per share. | 04 Mar 2021 | 350 | 26,565 (0%) | 0% | 192.2 | 67,284 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 194.32 per share. | 04 Mar 2021 | 25 | 26,915 (0%) | 0% | 194.3 | 4,858 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,035 | 2,035 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 1,686 | 27,340 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 186.18 per share. | 16 Dec 2020 | 435 | 25,654 (0%) | 0% | 186.2 | 80,988 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Sale of securities on an exchange or to another person at price $ 153.79 per share. | 06 Aug 2020 | 5,000 | 26,089 (0%) | 0% | 153.8 | 768,950 | Common Stock |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 5,000 | 5,850 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Ralf Kuriyel | Senior VP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.87 per share. | 06 Aug 2020 | 5,000 | 31,089 (0%) | 0% | 33.9 | 169,350 | Common Stock |